EXEL Dana Aftab sells $2.1M worth of shares
Feb 27, 2026, 5:33 AM
0.00%
What does EXEL do
Exelixis, an oncology company based in Alameda, California, focuses on developing treatments for difficult-to-treat cancers, with four marketed products including cabozantinib for various cancers. Founded in 2000, it employs 1,310 people.
Dana Aftab sold 47,918 shares of EXEL on 24 February at $44.50 per share, worth a total of $2.1M. They now own 616,106 EXEL shares, or a 7% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.